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Abstract:  
A study was undertaken to observe the effect of D-glucose and L-glutamine and the 
combination of both nutrients at various concentrations towards the growth and insulin 
production by BRIN-BD11 cells. It was found that at a final concentration of 4 g/L D-
glucose and 0.3 g/L L-glutamine in RPMI-1640 media gave maximum cell growth and 
insulin production of 1.75 x 106 cells/ml from 2.5 x 105 cells/ml and 100.77 µg/L, 
respectively. The result of this  study indicates that D-glucose and L-glutamine promote 
good cell growth and insulin secretion of BRIN-BD11 cells as a step towards mass 
propagation of transplantable insulinoma cells and insulin production.  
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I. INTRODUCTION  
Insulin derived from genetically engineered bacteria has been known to 
dominate the global insulin market for diabetic treatment in this century. However, 
apart from improving insulin production, the cell transplantation technology has 
recently gained much interest by many scientists in making the diabetic treatment 
permanent. Therefore, an anormous supply of healthy cells are needed for the 
theraphy. The cells may derived from patients either in the form of  primary 
isolated islet cells or cells developed from the stem cells. However, the short 
lifespan, small number of viable cells and low secretion of insulin posses by these 
cells were known to limit the understanding of their metabolism and functions.  
There are a number of insulinoma cell lines that have been developed through 
tissue cell engineering in order to overcome these limitations [1]. However, most 
of these insulinoma cell lines performed moderate to unresponsive towards certain 
concentrations of glucose in stimulating insulin secretory and drove the 
development of new hybrid insulinoma cell, the BRIN-BD11 cells [1]. The cells 
has gained much attention as a model cell in insulin related study due to its 
immortality and normal features of insulin biosynthesis and secretion from the 
normal pancreatic β-cell [1].  
The functions and effects of nutrients towards mammalian cell attachment, 
growth and propagation are important to avoid cell toxicity and apoptosis in order 
to stimulate maximum cell growth in media. Glucose and L-glutamine are two 
most important compounds that are normally formulated in the mammalian cell 
growth media such as the DMEM/Ham’s nutrients mixture F12, RPMI 1640 and 
serum-free hybridoma media at various concentrations [2]. 
 Glucose is a hexose sugar act as fuel to provide energy in cell metabolic 
pathways for cell to function [2]. D-glucose was found to stimulate insulin more 
than D-mannose and unresponsive with other hexose sugars by BRIN-BD11 cells 
[1]. 
The L-glutamine helps in synthesizing large amount of proteins and nucleic 
acids. Apart from that, it supports high energy to the rapidly dividing cell and cells 
that use glucose inefficiently [3].  
Our efforts in this study is to identify the optimum concentration of glucose and 
L-glutamine needed for BRIN cells to attach, grow and propagate towards the 
mass production of cells in tissue culture flask that could be used for future in 
bioreactor propagation for better insulin production.   
 
 
Objective:   To improve growth media formulation for growing of BRIN-BD11 cell and 
the secretion of insulin.  
 
 
II. MATERIALS AND METHODS 
A. Cell culture 
BRIN-BD11 cells were generously provided by Dr. Muhajir Hamid from Department 
of Microbiology, Faculty of Biotechnology and Biomelecular Sciences, Universiti Putra 
Malaysia. The cells were maintained in 25 cm2 T-flask (Orange Scientific, E.U.) 
containing 4.5 g/L D-glucose (Calbiochem, Germany) and 0.3 g/L L-glutamine 
(Amresco,USA) supplemented inRPMI-1640 growth media from Celgro, USA (2 g/L 
glucose without L-glutamine) (formulation recommended by ATCC [4] for epithelial 
cells), 10% fetal bovine serum, 100 U/ml penicillin and 0.1g/l streptomycin (both were 
from PAA, Austria) at pH 7.4 were then incubated in a CO2 incubator (Galaxy, RS 
Biotech, Germany) at 370C with 5% CO2 atmosphere. 
B. Preparation of cells  
The cells were detached by Accutase purchased from Innovative Cell Technologies, Inc., 
USA and was inoculated into a 175 cm2 vented-cap tissue culture flask containing the 
same growth media for maintaining the cell culture (same growth media as in section A) 
until 80% confluence. Then, 1 x 106 cell/ml was collected and washed three times with 
RPMI media (without D-glucose and L-glutamine) by 1000 rpm centrifugation 
(Centrifugal 5804 R, Eppendorf, Germany) at 40C for 15 minutes for each cycle. 
 
C. Culture media  
 
Excess amount of D-glucose and L-glutamine was added into the RPMI-1640 media 
(supplemented with 10% FBS and 100 U/ml penicillin and 0.1g/l streptomycin) to a 
different final concentrations of D-glucose (2, 4 and 6 g/L) and L-glutamine (0, 0.3 and 
0.6 g/L) and the combination of both D-glucose (D) and L-glutamine (L) (2(D) + 0.3 (L), 
2(D) + 0.6 (L), 4(D) + 0.3 (L), 4(D) + 0.6 (L), 6(D) + 0.3(L), 6(D) + 0.6(L) all in g/L).  
pH of the all media was adjusted to 7.4. 
 
D. Effect of Glucose and L-glutamine on cell culture 
 
Cells collected from section C were diluted into 2.5 x 105 cells/ml of prepared culture 
media. Then, 10 ml of the suspension was cultured into a 150 mm tissue culture dish 
(Orange Scientific, E.U.) and was incubated in a CO2 incubator at 370C with 5% CO2 
atmosphere. Daily sampling was done for 8 days. Media replacement was conducted 
when pH drop to 7 [5]. 
 
E. Sample analysis 
 
pH of the suspension was measured by using the pH probe and meter (Toledo, 
Switzerland), viable and non-viable cell number of both attached and suspension cells 
were counted using the Neubauer improved haemocytometer (Hirchmann EM 
Technocolour, England) under light microscope (Olympus CX21, China). Glucose and L-
glutamine concentrations of the suspension were measured by using the biochemical 
analyzer (YSI, USA). Enzyme immunoassay high range rat insulin ELISA (Mercodia, 
Sweden) was used to measure the insulin concentrations detected by ELISA reader (BIO-
TEK Instruments, Canada). 
  
 
       III, RESULTS 
A. Cell growth 
In this study, the optimum concentration of glucose and L-glutamine in stimulating the 
growth of BRIN-BD11 hybrid insulinoma cell and insulin production in RPMI-1640 
media supplemented with various concentrations of D-glucose and L-glutamine was 
observed. 
Figure 1, shows the growth profile of BRIN-BD11 cell culture in RPMI-1640 media 
containing different concentration of D-glucose, L-glutamine and the combination of 
both D-glucose and L-glutamine. The BRIN-BD11 culture manage to grow in RPMI-
1640 media containing low concentration of glucose and without L-glutamine reaching a 
cell density of 3.56 x 105 cells/ml at day 3 until it drop to  the lowest value of 1.97 x 104 
cells/ml at day 6.  
Culture in media consisting 4 g/L D-glucose and 0.3 g/L L-glutamine reach the highest 
peak of 1.75 x 106 cells/ml at day 7 from a starting culture number of 2.5 x 105 cells/ml. 
The second highest point was at the same day with cell density of 1.51 x 106 cells/ml in 
media supplemented with 6 g/L glucose and 0.3 g/L L-glutamine. Whereas, the third 
highest peak was at day 6 with 1.17 x 106 cells/ml in media containing 6 g/L glucose with 
0.6 g/L L-glutamine. 
 
 
 
Fig. 1 Attached viable cells in RPMI-1640 media supplemented with (□) 2 g/L D-glucose, 
(○) 2 g/L D-glucose with 0.3 g/L L-glutamine, (◊) 2 g/L D-glucose with 0.6 g/L L-
glutamine, (x) 4 g/L D-glucose, (▲) 4 g/L D-glucose with 0.3 g/L L-glutamine, (■) 4 g/L 
D-glutamine with 0.6 g/L L-glutamine, (∆) 6 g/L D-glucose, (●) 6 g/L D-glucose with 0.3 
g/L L-glutamine, (♦) 6 g/L D-glucose with 0.6 g/L L-glutamine 
  
B. Insulin production 
 
Insulin produced in RPMI-1640 media containing 2, 4 and 6 g/L D-glucose without L-
glutamine was able to produce as high as 0.92, 2.96 and 2.3 µg/L of insulin, respectively. 
The highest insulin produced was at day 2 with 100.77 µg/L insulin in RPMI-1640 
supplemented with 4g/L D-glucose and 0.3 g/L L-glutamine. Meanwhile, the second 
highest was 27.02 µg/L insulin produced after 24 hours in RPMI-1640  supplemented 
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with 2 g/L D-glucose and 0.3 g/L L-glutamine. The third highest peak appeared later at 
day 6 with 5.08 µg/L insulin produced in RPMI-1640 supplemented with 4 g/L D-
glucose and 0.6 g/L L-glutamine (Fig. 2). 
 
 
Fig. 2 Insulin produced by BRIN-BD11 cells in RPMI-1640 media supplemented with 
(□) 2 g/L D-glucose, (○) 2 g/L D-glucose with 0.3 g/L L-glutamine, (◊) 2 g/L D-glucose 
with 0.6 g/L L-glutamine, (x) 4 g/L D-glucose, (▲) 4 g/L D-glucose with 0.3 g/L L-
glutamine, (■) 4 g/L D-glutamine with 0.6 g/L L-glutamine, (∆) 6 g/L D-glucose, (●) 6 
g/L D-glucose with 0.3 g/L L-glutamine, (♦) 6 g/L D-glucose with 0.6 g/L L-glutamine 
 
C. D-glucose and L-glutamine uptake  
 
It was found that 25% and 66.7% of D-glucose and L-glutamine, respectively was 
consumed at the point where insulin was secreted at the highest insulin peak (100.77 
µg/L insulin) when culture was exposed in RPMI-1640 media supplemented with 
different concentrations of D-glucose and L-glutamine (figure 3 (a) and (b)). Meanwhile, 
19% and 46.7% of D-glucose and L-glutamine, respectively were consumed at the second 
highest insulin peak (27.02 µg/L insulin). At the third highest insulin peak (5.08 µg/L 
insulin), 16.7% and 43% of D-glucose and L-glutamine, respectively was consumed by 
the BRIN-BD11 culture. 
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Fig. 3 D-glucose (a) and L-glutamine (b) consumptions by BRIN-BD11 in RPMI-1640 
media supplemented with (□) 2 g/L D-glucose, (○) 2 g/L D-glucose with 0.3 g/L L-
glutamine, (◊) 2 g/L D-glucose with 0.6 g/L L-glutamine, (x) 4 g/L D-glucose, (▲) 4 g/L 
D-glucose with 0.3 g/L L-glutamine, (■) 4 g/L D-glutamine with 0.6 g/L L-glutamine, 
(∆) 6 g/L D-glucose, (●) 6 g/L D-glucose with 0.3 g/L L-glutamine, (♦) 6 g/L D-glucose 
with 0.6 g/L L-glutamine 
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IV.DISCUSSION 
 
This study was conducted to identify the optimum concentration of D-glucose and L-
glutamine to improve the BRIN-BD11 cell growth and insulin production. The RPMI-
1640 growth media was claimed to be the most suitable available commercial growth 
media for the BRIN-BD11 cells as it gave the best insulin release [6 ]. The commercial 
media available are normally formulated with glucose and glutamine at concentrations 
between 1 to 10 g/L and 0.073 to 1.46 g/L, respectively [2]. The requirement of these 
nutrients may vary from one cell line to the other.    
 
The BRIN-BD11 cells responsive towards sugars, amino acids, neurotransmitters, 
peptide hormones and drugs after the cells was cultured in RPMI-1640 media have 
shown good secretion of insulin [6].  
From the experiment, glucose and L-glutamine was heavily utilized in maintaining cell 
growth insulin production. Brennan, L. et al., (2002) [7] and Dixon, G. et al., (2003) [3] 
had claimed that glucose is consumed at high rates by primary rat islet cell and BRIN-
BD11 cell, and is closely related with in insulin secretion [8].  
The BRIN-BD11 culture manages to grow and survive even at a low concentration of 
glucose (2g/L) and without supplementation of L-glutamine in RPMI-1640 growth 
media. It was reported that glucose concentration above 0.64 g/L may trigger insulin 
production [9] and glucose involves in insulin release through the glucose 
phosphorylation process which depolarizes the cell membranes and activates exocytosis 
process which release insulin from β-cell [10]. However, insufficient glucose and 
glutamine supply will cause cell death and exposure to high glucose concentration will 
impair β-cell functions and reduce the cell sensitivity to secrete insulin. This situation has 
been observed through this study. Therefore, the right combination of both D-glucose and 
L-glutamine concentration is crucial for β-cell to perform.  
  The BRIN-BD11 culture grew and produced insulin best in media supplemented with 4 
g/L D-glucose and 0.3 g/L L-glutamine. In a study by McClenaghan, N. H. (1996) [1], 
BRIN-BD11 cells showed good response towards glucose concentration ranges between 
0.25 and 6.05 g/L within 20 min. Sufficient presence of D-glucose and L-glutamine in the 
media, when pH drop to 7, fresh media replacement helps to keep the nutrients available 
for the cells to grow and secrete insulin to the maximum. 
  Glutamine is an essential nutrient that is heavily utilized by in cell proliferation [11]. It 
also beneficial in dealing with metabolic stress as it may enhance cell survival [12]. 
Glutamine had to be present in 10 to 100 fold excess than any other amino acid in culture 
and could not be replaced by glutamic acid or glucose [13]. Glutamine has been reported 
to enhance glucose-stimulated insulin secretion from pancreatic β-cell, however, does not 
promote insulin secretion by itself due to tight regulation of glutamate dehydrogenase 
activity [14]. The presence of glutamine in the β-cell pathway cycle enhances glucose 
oxidation which later induces insulin exocytosis [13].  
 
 
 
 
 
 
III. CONCLUSIONS 
 
It can be concluded that good growth (1.75 x 106 cells/ml from 2.5 x 105 cells/m) and 
insulin production (100.77 µg/L) of BRIN-BD11 cells can be achieved together in RPMI-
1640 media supplemented with D-glucose and L-glutamine at concentrations of 4 g/L and 
0.3 g/L, respectively.  
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